CSL CEO McKenzie Steps Down After Board Points to Skills Gap

Paul McKenziePhotographer: Carla Gottgens/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Angus Whitley and Amber Tong

February 10, 2026 at 5:16 AM UTC

Updated on

February 10, 2026 at 7:43 AM UTC

CSL Ltd. Chief Executive Officer Paul McKenzie is stepping down effective immediately, just months after the company scrapped a short-lived plan to spin off its Seqirus vaccine business.

The abrupt departure also comes a day before the Australian healthcare company reports earnings. Former senior executive and non-executive director Gordon Naylor has been named interim CEO while the company hunts for a permanent successor, CSL said in a statement Tuesday.